Top Markets
Coin of the day
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Rangering i aksjer #42678
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Aksjekurs
$0.00001
Sist synkronisert: 2026-07-30
Markedsverdi
$426.00
Endring (1 dag)
0.00%
Endring (1 år)
-90.00%
Land
US
Handel Kaleido Biosciences, Inc. (KLDO)

Kategori

EPS for Kaleido Biosciences, Inc. (KLDO)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Kaleido Biosciences, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Kaleido Biosciences, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter